Latest News & Features
Americas
Japanese pharmaceutical company Hisamitsu and its US-based subsidiary Noven have sued Mylan for allegedly infringing two patents covering oestrogen patch Minivelle. 27 April 2015
Americas
Drug maker Shire, alongside two other companies, has sued Amneal Pharmaceuticals for allegedly infringing a patent related to Lialda, a drug for treating ulcerative colitis. 24 April 2015
Biotechnology
Biotechnology companies are concerned about the Dutch government’s plans to allow small plant breeders to develop new breeds while avoiding paying licensing fees, according to reports. 23 April 2015
Europe
In the second instalment of a regular column on the unitary patent and Unified Patent Court by law firm Taylor Wessing, Paul England and Simon Cohen discuss how watching the new system will also mean monitoring the old one. 23 April 2015
Asia
Pharmaceutical company Teva has offered to buy fellow drug maker Mylan in a deal that could be worth $40 billion. 22 April 2015
Americas
The Supreme Court of Canada has dismissed an appeal by French pharmaceutical company Sanofi in its patent dispute with Canadian generic drug maker Apotex. 22 April 2015
Americas
Texas hedge fund manager Kyle Bass has sought another inter partes review, this time to challenge a patent covering Pharmacyclics’ cancer drug Imbruvica. 22 April 2015
Americas
Healthcare company Fresenius Kabi and India-based generic drug maker Claris Lifesciences have settled their patent dispute, ending pending litigation. 21 April 2015
Big Pharma
Law firm Taylor Wessing has promoted senior associates Matt Royle and Ed Vickers to partner and senior counsel, respectively. 21 April 2015
Americas
Mylan’s executive chairman Robert Coury has issued a statement confirming that his company and Teva will not merge. 20 April 2015